Cargando…
Stratified approaches for using biomarkers in phenotyping for the management of severe asthma in India
Various respiratory societies including the Global Initiative for Asthma (GINA), European Respiratory Society (ERS) and American Thoracic Society (ATS) define severe asthma as asthma that requires or remains uncontrolled despite treatment with systemic corticosteroids or high-dose inhaled corticoste...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926217/ https://www.ncbi.nlm.nih.gov/pubmed/34975055 http://dx.doi.org/10.4103/lungindia.lungindia_129_21 |
_version_ | 1784670191675768832 |
---|---|
author | Talwar, Deepak Singh, Sarvinder Marwah, Vikas Asawale, Ketan Bhushan, Bharat |
author_facet | Talwar, Deepak Singh, Sarvinder Marwah, Vikas Asawale, Ketan Bhushan, Bharat |
author_sort | Talwar, Deepak |
collection | PubMed |
description | Various respiratory societies including the Global Initiative for Asthma (GINA), European Respiratory Society (ERS) and American Thoracic Society (ATS) define severe asthma as asthma that requires or remains uncontrolled despite treatment with systemic corticosteroids or high-dose inhaled corticosteroids plus another controller such as long acting beta agonist. The management of asthma as an entity is not straightforward due to inter-individual variability in assessment parameters. With the advent of science, targeted therapies are on the emergence for management of severe asthma. A biomarker can be used as a surrogate to phenotype a patient as well as to measure the response to therapy with any drug. Biomarkers have been critical for studies of disease pathogenesis and the development of new therapies in severe asthma. From a resource constraint perspective like countries in India, it is imperative to use biomarkers that are easily available are affordable cost. Choosing an ideal biomarkers is also important from a perspective of choosing a particular therapy. The cost associated with the biologicals is high and it is imperative to gauge the treatment effectiveness with the therapy at the earliest considering the out of pocket spends of the patients. |
format | Online Article Text |
id | pubmed-8926217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-89262172022-03-17 Stratified approaches for using biomarkers in phenotyping for the management of severe asthma in India Talwar, Deepak Singh, Sarvinder Marwah, Vikas Asawale, Ketan Bhushan, Bharat Lung India Review Article Various respiratory societies including the Global Initiative for Asthma (GINA), European Respiratory Society (ERS) and American Thoracic Society (ATS) define severe asthma as asthma that requires or remains uncontrolled despite treatment with systemic corticosteroids or high-dose inhaled corticosteroids plus another controller such as long acting beta agonist. The management of asthma as an entity is not straightforward due to inter-individual variability in assessment parameters. With the advent of science, targeted therapies are on the emergence for management of severe asthma. A biomarker can be used as a surrogate to phenotype a patient as well as to measure the response to therapy with any drug. Biomarkers have been critical for studies of disease pathogenesis and the development of new therapies in severe asthma. From a resource constraint perspective like countries in India, it is imperative to use biomarkers that are easily available are affordable cost. Choosing an ideal biomarkers is also important from a perspective of choosing a particular therapy. The cost associated with the biologicals is high and it is imperative to gauge the treatment effectiveness with the therapy at the earliest considering the out of pocket spends of the patients. Wolters Kluwer - Medknow 2022 2021-12-28 /pmc/articles/PMC8926217/ /pubmed/34975055 http://dx.doi.org/10.4103/lungindia.lungindia_129_21 Text en Copyright: © 2021 Indian Chest Society https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Article Talwar, Deepak Singh, Sarvinder Marwah, Vikas Asawale, Ketan Bhushan, Bharat Stratified approaches for using biomarkers in phenotyping for the management of severe asthma in India |
title | Stratified approaches for using biomarkers in phenotyping for the management of severe asthma in India |
title_full | Stratified approaches for using biomarkers in phenotyping for the management of severe asthma in India |
title_fullStr | Stratified approaches for using biomarkers in phenotyping for the management of severe asthma in India |
title_full_unstemmed | Stratified approaches for using biomarkers in phenotyping for the management of severe asthma in India |
title_short | Stratified approaches for using biomarkers in phenotyping for the management of severe asthma in India |
title_sort | stratified approaches for using biomarkers in phenotyping for the management of severe asthma in india |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926217/ https://www.ncbi.nlm.nih.gov/pubmed/34975055 http://dx.doi.org/10.4103/lungindia.lungindia_129_21 |
work_keys_str_mv | AT talwardeepak stratifiedapproachesforusingbiomarkersinphenotypingforthemanagementofsevereasthmainindia AT singhsarvinder stratifiedapproachesforusingbiomarkersinphenotypingforthemanagementofsevereasthmainindia AT marwahvikas stratifiedapproachesforusingbiomarkersinphenotypingforthemanagementofsevereasthmainindia AT asawaleketan stratifiedapproachesforusingbiomarkersinphenotypingforthemanagementofsevereasthmainindia AT bhushanbharat stratifiedapproachesforusingbiomarkersinphenotypingforthemanagementofsevereasthmainindia |